Cargando…
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma
INTRODUCTION: Syndecan-1 (SDC1) has multiple functions in tumorigenesis in general and specifically in pancreatic cancer. We aimed to evaluate SDC1 as a diagnostic and prognostic biomarker in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: In this case-control study, patients newly d...
Autores principales: | Yablecovitch, Doron, Ben-Horin, Shomron, Picard, Orit, Yavzori, Miri, Fudim, Ella, Nadler, Moshe, Levy, Idan, Sakhnini, Emad, Lang, Alon, Engel, Tal, Lahav, Maor, Saker, Talia, Neuman, Sandra, Selinger, Limor, Dvir, Revital, Raitses-Gurevich, Maria, Golan, Talia, Laish, Ido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132524/ https://www.ncbi.nlm.nih.gov/pubmed/35297817 http://dx.doi.org/10.14309/ctg.0000000000000473 |
Ejemplares similares
-
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysis
por: Yablecovitch, Doron, et al.
Publicado: (2019) -
Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease
por: Ukashi, Offir, et al.
Publicado: (2023) -
Acute Chest Pain as an Infusion Reaction to Vedolizumab
por: Levartovsky, Asaf, et al.
Publicado: (2022) -
Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
por: Levartovsky, Asaf, et al.
Publicado: (2023) -
Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals
por: Ukashi, Offir, et al.
Publicado: (2022)